Latest On Fate Therapeutics, Inc (FATE):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-24 02:16 EST | News | Fate Therapeutics: The Future Remains Cloudy | N/A |  |
| 2023-05-03 23:29 EST | News | Fate Therapeutics GAAP EPS of -$0.19 beats by $0.47, revenue of $58.98M beats by $25.45M | N/A | |
| 2023-05-03 23:28 EST | News | Fate Therapeutics, Inc. (FATE) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-02 22:13 EST | News | Fate Therapeutics Q1 2023 Earnings Preview | N/A | |
| 2023-03-24 09:55 EST | News | Fate Therapeutics: If You Are Comparing With Geron, Do It Thoroughly | N/A | |
| 2023-03-01 10:39 EST | News | Fate Therapeutics, Inc. (FATE) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-28 19:51 EST | News | Fate Therapeutics GAAP EPS of -$0.58 beats by $0.29, revenue of $44.34M beats by $25.93M | N/A | |
| 2023-02-28 04:23 EST | News | Fate Therapeutics Q4 2022 Earnings Preview | N/A | |
| 2023-01-07 01:07 EST | News | Fate faces slew of analyst downgrades after J&J's Janssen unit ends agreement | N/A | |
| 2023-01-05 22:49 EST | News | Fate Therapeutics shares crater ~50% on ending tie-up with Janssen, layoffs | N/A | |
| 2023-01-05 08:48 EST | News | Fate Therapeutics: iPSC Pioneer A Buy For Long-Term Investors | N/A | |
| 2022-12-22 14:42 EST | News | Fate Therapeutics falls 6% after Oppenheimer downgrades rating to Perform | N/A | |
| 2022-12-16 03:17 EST | News | Fate Therapeutics extends losses as Goldman initiates at Sell | N/A | |
| 2022-12-12 13:06 EST | News | Fate Therapeutics hits 52-week low after preclinical data on leukemia treatment | N/A | |
| 2022-11-16 11:24 EST | News | Fate Therapeutics: Promising Potential, Agonizingly Slow Progress | N/A | |
| 2022-11-15 01:50 EST | News | Fate Therapeutics: Returning To The Ticker That Changed The Way I Invest | N/A | |
| 2022-11-04 02:21 EST | News | Fate Therapeutics GAAP EPS of -$0.86 beats by $0.04, revenue of $14.98M misses by $0.51M | N/A | |
| 2022-11-04 02:20 EST | News | Fate Therapeutics, Inc. (FATE) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-03 08:43 EST | News | Fate Therapeutics Q3 2022 Earnings Preview | N/A | |
| 2022-08-30 20:33 EST | News | Fate Therapeutics: Yes For Speculators, No For Defensive Investors | N/A | |
| 2022-08-18 13:32 EST | News | Fate Therapeutics gains as Wells Fargo cites upcoming catalysts | N/A | |
| 2022-08-05 02:30 EST | News | Fate Therapeutics Inc. (FATE) CEO Scott Wolchko on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-03 20:24 EST | News | Fate Therapeutics GAAP EPS of -$0.79 beats by $0.04, revenue of $18.55M beats by $5.99M | N/A | |
| 2022-08-03 05:44 EST | News | Fate Therapeutics Q2 2022 Earnings Preview | N/A | |
| 2022-07-28 23:27 EST | News | Needham initiates Fate Therapeutics coverage on potential of stem cell therapies | N/A | |
| 2022-07-01 04:26 EST | News | Fate Therapeutics names Brian Powl as chief commercial officer | N/A | |
| 2022-06-28 22:46 EST | News | Fate, Ono expand team up on cancer immunotherapy program | N/A | |
| 2022-06-04 00:17 EST | News | Fate: Possible Speedy FDA Approval Process With RMAT Designation | N/A | |
| 2022-05-05 03:04 EST | News | Fate Therapeutics GAAP EPS of -$0.68 beats by $0.11, revenue of $18.4M beats by $9.39M | N/A | |
| 2022-05-05 03:03 EST | News | Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-04 06:19 EST | News | Fate Therapeutics Q1 2022 Earnings Preview | N/A | |
| 2022-03-01 06:16 EST | News | Fate Therapeutics GAAP EPS of -$0.72 misses by $0.04, revenue of $17.07M beats by $5.52M | N/A | |
| 2022-03-01 06:15 EST | News | Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-28 10:17 EST | News | Fate Therapeutics Q4 2021 Earnings Preview | N/A | |
| 2022-02-21 08:17 EST | News | Fate Therapeutics: Slowly Getting To An Attractive Position | N/A | |
| 2022-02-11 21:06 EST | News | Fate Therapeutics (FATE) Investor Presentation - Slideshow | N/A | |
| 2022-02-01 08:32 EST | News | One of the largest biotech ETFs has the second highest short interest float of U.S. ETFs | N/A | |
| 2021-12-28 07:04 EST | News | Century, Fate drop after FDA’s Fast Track status for Celularity’s NK cell candidate | N/A | |
| 2021-12-16 06:26 EST | News | Fate Therapeutics upgraded at Wedbush after data for off-the-shelf candidates | N/A | |
| 2021-12-13 19:18 EST | News | Fate up 5% after hours on interim phase 1 data on B-cell lymphoma candidate | N/A | |
| 2021-12-08 06:01 EST | News | Fate Therapuetics rises 13% on outperform initiation from Cowen | N/A | |
| 2021-12-06 15:08 EST | News | Fate Therapeutics: Data Playing Catchup With Valuation | N/A | |
| 2021-11-10 07:30 EST | News | Fate Therapeutics upgraded at Citi on valuation ahead of key catalysts | N/A | |
| 2021-11-05 05:31 EST | News | Fate Therapeutics EPS beats by $0.13, beats on revenue | N/A | |
| 2021-11-05 05:29 EST | News | Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-04 08:32 EST | News | Fate Therapeutics Q3 2021 Earnings Preview | N/A | |
| 2021-10-13 00:32 EST | News | Warning: FATE is at high risk of performing badly | N/A | |
| 2021-10-07 09:57 EST | News | FATE is at high risk of performing badly | N/A | |
| 2021-09-29 14:49 EST | News | Warning: FATE has been downgraded to Very Bearish | N/A | |
| 2021-09-21 17:49 EST | News | Fate Therapeutics posts encouraging data from FT538 preclinical study | N/A | |
About Fate Therapeutics, Inc (FATE):
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors, as well as ProTmune for the treatment of hematologic malignancies and rare genetic disorders. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
General
- Name Fate Therapeutics, Inc
- Symbol FATE
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 279
- Fiscal Year EndDecember
- IPO Date2013-10-01
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.fatetherapeutics.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 231.92
- Price/Book (Most Recent Quarter) 21.59
- Enterprise Value Revenue 251.74
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.86
- Next Year EPS Estimate -$2.17
- Next Quarter EPS Estimate -$0.41
- Operating Margin -407%
- Return on Assets -17%
- Return on Equity -55%
- Revenue 31.43 million
- Earnings Per Share -$1.22
- Revenue Per Share $0.38
- Gross Profit -94189000
- Quarterly Earnings Growth 467.3%
View More
Highlights
- Market Capitalization 8.06 billion
- EBITDA -76343000
- PE Ratio -2.38
- Analyst Target Price $113.65
- Book Value Per Share $4.38
View More
Share Statistics
- Shares Outstanding 93.78 million
- Shares Float 79.71 million
- % Held by Insiders 179%
- % Held by Institutions 100.89%
- Shares Short 10.3 million
- Shares Short Prior Month 9.63 million
- Short Ratio 11
- Short % of Float 15%
- Short % of Shares Outstanding 11%
View More
Technicals
- Beta 1.65
- 52 Week High $121.16
- 52 Week Low $19.81
- 50 Day Moving Average 95.77
- 200 Day Moving Average 71.47
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Fate Therapeutics, Inc (FATE) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Fate Therapeutics, Inc (FATE) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-24 | $15.9 million | -$0.61 | -$0.38 | -61.55% |
| 2020-09-30 | 2020-11-05 | $7.56 million | -$0.68 | -$0.36 | -88.84% |
| 2020-06-30 | 2020-08-05 | $5.47 million | -$0.35 | -$0.29 | -19.49% |
| 2020-03-31 | 2020-05-11 | $2.52 million | -$0.44 | -$0.39 | -12.88% |
| 2019-12-31 | 2020-03-02 | $2.8 million | -$0.37 | -$0.37 | 1.25% |
| 2019-09-30 | 2019-11-05 | $2.43 million | -$0.40 | -$0.36 | -10.13% |
| 2019-06-30 | 2019-08-06 | $2.82 million | -$0.36 | -$0.31 | -16.92% |
| 2019-03-31 | 2019-05-07 | $2.63 million | -$0.30 | -$0.23 | -32.04% |
| 2018-12-31 | 2019-03-05 | $1.66 million | -$0.25 | -$0.24 | -3.01% |
| 2018-09-30 | 2018-11-01 | $1.03 million | -$0.31 | -$0.28 | -12.36% |
| 2018-06-30 | 2018-08-06 | $1.03 million | -$0.37 | -$0.32 | -16.5% |
| 2018-03-31 | 2018-05-10 | $1.03 million | -$0.27 | -$0.22 | -22.73% |
| 2017-12-31 | 2018-03-05 | $1.03 million | -$0.29 | -$0.25 | -16% |
| 2017-09-30 | 2017-11-01 | $1.03 million | -$0.26 | -$0.25 | -3.03% |
| 2017-06-30 | 2017-08-14 | $1.03 million | -$0.23 | -$0.23 | 0.86% |
| 2017-03-31 | 2017-05-15 | $1.03 million | -$0.24 | -$0.20 | -22.45% |
| 2016-12-31 | 2017-03-16 | $1.03 million | -$0.21 | -$0.28 | 26.06% |
| 2016-09-30 | 2016-11-07 | $1.03 million | -$0.27 | -$0.28 | 4.15% |
| 2016-06-30 | 2016-08-08 | $1.03 million | -$0.29 | -$0.31 | 5.84% |
| 2016-03-31 | 2016-05-09 | $1.32 million | -$0.29 | -$0.27 | -8.74% |
| 2015-12-31 | 2016-03-03 | $1.08 million | -$0.26 | -$0.27 | 1.89% |
| 2015-09-30 | 2015-11-03 | $1.03 million | -$0.24 | -$0.30 | 20% |
| 2015-06-30 | 2015-08-05 | $329000 | -$0.33 | -$0.39 | 15.38% |
| 2015-03-31 | 2015-05-07 | $N/A | -$0.38 | -$0.36 | -5.56% |
| 2014-12-31 | 2015-03-12 | $N/A | -$0.30 | -$0.31 | 3.23% |
| 2014-09-30 | 2014-11-11 | $N/A | -$0.32 | -$0.33 | 3.03% |
| 2014-06-30 | 2014-08-12 | $N/A | -$0.30 | -$0.37 | 18.92% |
| 2014-03-31 | 2014-05-13 | $N/A | -$0.34 | -$0.33 | -3.03% |
| 2013-12-31 | 2014-03-17 | $762000 | -$0.29 | -$0.27 | -7.41% |
| 2013-09-30 | 2013-11-13 | $209000 | -$4.81 | -$0.32 | -1403.13% |
Fate Therapeutics, Inc (FATE) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Fate Therapeutics, Inc (FATE) Chart:
Fate Therapeutics, Inc (FATE) News:
Below you will find a list of latest news for Fate Therapeutics, Inc (FATE) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Fate Therapeutics, Inc (FATE) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-21 | 0.5 | 0 | CALL | 0 | 0 | 635.75 | TRUE | 0 | 0 |
| 2025-03-21 | 1 | 0 | CALL | 0 | 0 | 190.94 | TRUE | 0 | 0 |
| 2025-03-21 | 1.5 | 0.3 | CALL | 2 | 102 | 161.84 | TRUE | -0.1 | -0.25 |
| 2025-03-21 | 2 | 0.1 | CALL | 41 | 40 | 135.35 | FALSE | -0.15 | -0.6 |
| 2025-03-21 | 3 | 0.05 | CALL | 0 | 2 | 321.47 | FALSE | 0 | 0 |
| 2025-03-21 | 4 | 0 | CALL | 0 | 0 | 379.02 | FALSE | 0 | 0 |
| 2025-03-21 | 5 | 0 | CALL | 0 | 0 | 566.68 | FALSE | 0 | 0 |
| 2025-03-21 | 0.5 | 0 | PUT | 0 | 0 | 287.99 | FALSE | 0 | 0 |
| 2025-03-21 | 1 | 0 | PUT | 0 | 0 | 306.49 | FALSE | 0 | 0 |
| 2025-03-21 | 1.5 | 0.25 | PUT | 0 | 24 | 116.82 | FALSE | 0 | 0 |
| 2025-03-21 | 2 | 0 | PUT | 0 | 0 | 166.94 | TRUE | 0 | 0 |
| 2025-03-21 | 3 | 0 | PUT | 0 | 0 | 206.14 | TRUE | 0 | 0 |
| 2025-03-21 | 4 | 0 | PUT | 0 | 0 | 280.5 | TRUE | 0 | 0 |
| 2025-03-21 | 5 | 0 | PUT | 0 | 0 | 271.98 | TRUE | 0 | 0 |
| 2025-04-17 | 0.5 | 0 | CALL | 0 | 0 | 391.38 | TRUE | 0 | 0 |
| 2025-04-17 | 1 | 0 | CALL | 0 | 0 | 91.79 | TRUE | 0 | 0 |
| 2025-04-17 | 1.5 | 0 | CALL | 0 | 0 | 83.14 | TRUE | 0 | 0 |
| 2025-04-17 | 2 | 0 | CALL | 0 | 0 | 161.37 | FALSE | 0 | 0 |
| 2025-04-17 | 3 | 0 | CALL | 0 | 0 | 208.93 | FALSE | 0 | 0 |
| 2025-04-17 | 4 | 0 | CALL | 0 | 0 | 249.73 | FALSE | 0 | 0 |
| 2025-04-17 | 5 | 0 | CALL | 0 | 0 | 278.66 | FALSE | 0 | 0 |
| 2025-04-17 | 0.5 | 0 | PUT | 0 | 0 | 207.75 | FALSE | 0 | 0 |
| 2025-04-17 | 1 | 0 | PUT | 0 | 0 | 188.87 | FALSE | 0 | 0 |
| 2025-04-17 | 1.5 | 0 | PUT | 0 | 0 | 95.77 | FALSE | 0 | 0 |
| 2025-04-17 | 2 | 0.63 | PUT | 32 | 0 | 134.72 | TRUE | 0.63 | 0 |
| 2025-04-17 | 3 | 0 | PUT | 0 | 0 | 116.17 | TRUE | 0 | 0 |
| 2025-04-17 | 4 | 0 | PUT | 0 | 0 | 174.12 | TRUE | 0 | 0 |
| 2025-04-17 | 5 | 0 | PUT | 0 | 0 | 235.61 | TRUE | 0 | 0 |
| 2025-05-16 | 0.5 | 0 | CALL | 0 | 0 | 263.79 | TRUE | 0 | 0 |
| 2025-05-16 | 1 | 0.8 | CALL | 0 | 198 | 151.44 | TRUE | 0 | 0 |
| 2025-05-16 | 1.5 | 0.15 | CALL | 0 | 151 | 174.54 | TRUE | 0 | 0 |
| 2025-05-16 | 2 | 0.4 | CALL | 0 | 315 | 138.84 | FALSE | 0 | 0 |
| 2025-05-16 | 3 | 0.05 | CALL | 0 | 186 | 212.66 | FALSE | 0 | 0 |
| 2025-05-16 | 4 | 0.05 | CALL | 0 | 39 | 202.32 | FALSE | 0 | 0 |
| 2025-05-16 | 5 | 0.15 | CALL | 0 | 643 | 244.52 | FALSE | 0 | 0 |
| 2025-05-16 | 6 | 0.05 | CALL | 0 | 301 | 253.56 | FALSE | 0 | 0 |
| 2025-05-16 | 7 | 0.2 | CALL | 0 | 85 | 248.42 | FALSE | 0 | 0 |
| 2025-05-16 | 8 | 0.08 | CALL | 0 | 172 | 308.5 | FALSE | 0 | 0 |
| 2025-05-16 | 0.5 | 0 | PUT | 0 | 0 | 169.07 | FALSE | 0 | 0 |
| 2025-05-16 | 1 | 0 | PUT | 0 | 0 | 153.97 | FALSE | 0 | 0 |
| 2025-05-16 | 1.5 | 0 | PUT | 0 | 0 | 113.9 | FALSE | 0 | 0 |
| 2025-05-16 | 2 | 0.75 | PUT | 0 | 23 | 151.4 | TRUE | 0 | 0 |
| 2025-05-16 | 3 | 1.74 | PUT | 0 | 13 | 157.19 | TRUE | 0 | 0 |
| 2025-05-16 | 4 | 2.66 | PUT | 0 | 13 | 181.74 | TRUE | 0 | 0 |
| 2025-05-16 | 5 | 1.83 | PUT | 0 | 0 | 168.87 | TRUE | 0 | 0 |
| 2025-05-16 | 6 | 0 | PUT | 0 | 0 | 214.99 | TRUE | 0 | 0 |
| 2025-05-16 | 7 | 0 | PUT | 0 | 0 | 253.63 | TRUE | 0 | 0 |
| 2025-05-16 | 8 | 6.1 | PUT | 0 | 0 | 267.7 | TRUE | 0 | 0 |
| 2025-08-15 | 0.5 | 0 | CALL | 0 | 0 | 139.21 | TRUE | 0 | 0 |
| 2025-08-15 | 1 | 0.79 | CALL | 0 | 11 | 149.33 | TRUE | 0 | 0 |
| 2025-08-15 | 1.5 | 0.55 | CALL | 0 | 809 | 139.75 | TRUE | 0 | 0 |
| 2025-08-15 | 2 | 0.47 | CALL | 0 | 31 | 112.83 | FALSE | 0 | 0 |
| 2025-08-15 | 3 | 0.4 | CALL | 0 | 7 | 128.98 | FALSE | 0 | 0 |
| 2025-08-15 | 4 | 0 | CALL | 0 | 0 | 170.69 | FALSE | 0 | 0 |
| 2025-08-15 | 5 | 0.15 | CALL | 0 | 4 | 187.58 | FALSE | 0 | 0 |
| 2025-08-15 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-08-15 | 1 | 0 | PUT | 0 | 0 | 127.01 | FALSE | 0 | 0 |
| 2025-08-15 | 1.5 | 0 | PUT | 0 | 0 | 112.76 | FALSE | 0 | 0 |
| 2025-08-15 | 2 | 0.81 | PUT | 0 | 70 | 131.7 | TRUE | 0 | 0 |
| 2025-08-15 | 3 | 0 | PUT | 0 | 0 | 132.86 | TRUE | 0 | 0 |
| 2025-08-15 | 4 | 0 | PUT | 0 | 0 | 139.66 | TRUE | 0 | 0 |
| 2025-08-15 | 5 | 0 | PUT | 0 | 0 | 143.71 | TRUE | 0 | 0 |
Latest FATE Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 63 | $17.82 |
| Jun 13, 2022 7:59 PM EST | 1 | $17.815 |
| Jun 13, 2022 7:59 PM EST | 27 | $17.81 |
| Jun 13, 2022 7:59 PM EST | 100 | $17.81 |
| Jun 13, 2022 7:59 PM EST | 100 | $17.81 |
Fate Therapeutics, Inc (FATE) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-18 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1434316/000110465920074302/0001104659-20-074302-index.htm |
| 2019-01-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1434316/000003877719000001/0000038777-19-000001-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1434316/000021545719006846/0000215457-19-006846-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1434316/000031506619001046/0000315066-19-001046-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1434316/000031506620000995/0000315066-20-000995-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1434316/000083423720005406/0000834237-20-005406-index.htm |
| 2018-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924318030904/0000899243-18-030904-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031090/0000899243-18-031090-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031217/0000899243-18-031217-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm |
| 2018-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031703/0000899243-18-031703-index.htm |
| 2019-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924319001724/0000899243-19-001724-index.htm |
| 2019-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002114/0000899243-19-002114-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002196/0000899243-19-002196-index.htm |
| 2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002256/0000899243-19-002256-index.htm |
| 2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002335/0000899243-19-002335-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924319014037/0000899243-19-014037-index.htm |
| 2019-07-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm |
| 2019-07-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm |
| 2019-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm |
| 2020-01-31 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1434316/000104018820000081/0001040188-20-000081-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000110465920056896/0001104659-20-056896-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000110465920056897/0001104659-20-056897-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000110465920074301/0001104659-20-074301-index.htm |
| 2020-06-18 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1434316/000110465920074302/0001104659-20-074302-index.htm |
| 2018-09-27 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1434316/000114420418051218/0001144204-18-051218-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000114420418051219/0001144204-18-051219-index.htm |
| 2019-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000114420419023892/0001144204-19-023892-index.htm |
| 2019-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000114420419023893/0001144204-19-023893-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000114420419037477/0001144204-19-037477-index.htm |
| 2019-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000114420419044910/0001144204-19-044910-index.htm |
| 2019-09-17 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1434316/000114420419044911/0001144204-19-044911-index.htm |
| 2018-09-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1434316/000119312518278765/0001193125-18-278765-index.htm |
| 2018-09-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1434316/000119312518280061/0001193125-18-280061-index.htm |
| 2018-11-21 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1434316/000119312518332350/0001193125-18-332350-index.htm |
| 2018-11-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000119312518332391/0001193125-18-332391-index.htm |
| 2018-12-21 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1434316/000119312518356424/0001193125-18-356424-index.htm |
| 2019-02-08 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1434316/000119312519032261/0001193125-19-032261-index.htm |
| 2019-03-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1434316/000119312519083478/0001193125-19-083478-index.htm |
| 2019-04-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1434316/000119312519100680/0001193125-19-100680-index.htm |
| 2019-09-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1434316/000119312519242947/0001193125-19-242947-index.htm |
| 2019-09-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1434316/000119312519244195/0001193125-19-244195-index.htm |
| 2019-09-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000119312519244198/0001193125-19-244198-index.htm |
| 2020-03-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1434316/000119312520080623/0001193125-20-080623-index.htm |
| 2020-03-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1434316/000119312520080634/0001193125-20-080634-index.htm |
| 2020-06-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1434316/000119312520163472/0001193125-20-163472-index.htm |
| 2020-06-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1434316/000119312520164911/0001193125-20-164911-index.htm |
| 2020-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000119312520164916/0001193125-20-164916-index.htm |
| 2019-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119003019/0001209191-19-003019-index.htm |
| 2019-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm |
| 2019-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119003022/0001209191-19-003022-index.htm |
| 2019-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119003023/0001209191-19-003023-index.htm |
| 2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119014022/0001209191-19-014022-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119016098/0001209191-19-016098-index.htm |
| 2019-03-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119019968/0001209191-19-019968-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119019972/0001209191-19-019972-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119020986/0001209191-19-020986-index.htm |
| 2019-03-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119021717/0001209191-19-021717-index.htm |
| 2019-04-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm |
| 2019-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119027945/0001209191-19-027945-index.htm |
| 2019-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119027946/0001209191-19-027946-index.htm |
| 2019-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119027949/0001209191-19-027949-index.htm |
| 2019-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119027950/0001209191-19-027950-index.htm |
| 2019-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119027951/0001209191-19-027951-index.htm |
| 2019-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119027952/0001209191-19-027952-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119032958/0001209191-19-032958-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119039461/0001209191-19-039461-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119042382/0001209191-19-042382-index.htm |
| 2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119042386/0001209191-19-042386-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119053272/0001209191-19-053272-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119053275/0001209191-19-053275-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119053277/0001209191-19-053277-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119053280/0001209191-19-053280-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919119061760/0001209191-19-061760-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120000242/0001209191-20-000242-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120003025/0001209191-20-003025-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120003026/0001209191-20-003026-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120003027/0001209191-20-003027-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120003031/0001209191-20-003031-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120005968/0001209191-20-005968-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120006263/0001209191-20-006263-index.htm |
| 2020-03-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120021788/0001209191-20-021788-index.htm |
| 2020-05-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120027055/0001209191-20-027055-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120027063/0001209191-20-027063-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120027069/0001209191-20-027069-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120027078/0001209191-20-027078-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120027086/0001209191-20-027086-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120027090/0001209191-20-027090-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120027100/0001209191-20-027100-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120027107/0001209191-20-027107-index.htm |
| 2020-08-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120047476/0001209191-20-047476-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120047483/0001209191-20-047483-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120050681/0001209191-20-050681-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120053043/0001209191-20-053043-index.htm |
| 2020-10-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120055368/0001209191-20-055368-index.htm |
| 2020-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm |
| 2020-04-21 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1434316/000143431620000001/0001434316-20-000001-index.htm |
| 2020-07-06 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1434316/000143431620000002/0001434316-20-000002-index.htm |
| 2018-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459018023467/0001564590-18-023467-index.htm |
| 2018-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459018026210/0001564590-18-026210-index.htm |
| 2018-11-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1434316/000156459018026214/0001564590-18-026214-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459018027760/0001564590-18-027760-index.htm |
| 2019-01-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459019000184/0001564590-19-000184-index.htm |
| 2019-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459019006257/0001564590-19-006257-index.htm |
| 2019-03-05 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1434316/000156459019006258/0001564590-19-006258-index.htm |
| 2019-03-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1434316/000156459019006990/0001564590-19-006990-index.htm |
| 2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459019008253/0001564590-19-008253-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459019016475/0001564590-19-016475-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459019016519/0001564590-19-016519-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1434316/000156459019016536/0001564590-19-016536-index.htm |
| 2019-07-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459019025146/0001564590-19-025146-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459019029319/0001564590-19-029319-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1434316/000156459019029333/0001564590-19-029333-index.htm |
| 2019-08-07 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459019030033/0001564590-19-030033-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459019040354/0001564590-19-040354-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1434316/000156459019040360/0001564590-19-040360-index.htm |
| 2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459019043510/0001564590-19-043510-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459020000753/0001564590-20-000753-index.htm |
| 2020-03-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459020008139/0001564590-20-008139-index.htm |
| 2020-03-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1434316/000156459020008141/0001564590-20-008141-index.htm |
| 2020-03-02 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1434316/000156459020008196/0001564590-20-008196-index.htm |
| 2020-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459020015011/0001564590-20-015011-index.htm |
| 2020-04-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459020019242/0001564590-20-019242-index.htm |
| 2020-05-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459020021242/0001564590-20-021242-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459020024158/0001564590-20-024158-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1434316/000156459020024213/0001564590-20-024213-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459020036776/0001564590-20-036776-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1434316/000156459020036806/0001564590-20-036806-index.htm |
| 2020-08-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459020040672/0001564590-20-040672-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1434316/000156459020051284/0001564590-20-051284-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1434316/000156459020051301/0001564590-20-051301-index.htm |
| 2019-02-27 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1434316/999999999719000597/9999999997-19-000597-index.htm |
Fate Therapeutics, Inc (FATE) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Fate Therapeutics, Inc (FATE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 179%Institutional Ownership: 10089%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-11-05 | CINDY TAHL | General Counsel and Secretary | Sell | 16,682.00 | 50.55 | 843,253.41 | 102,118.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm |
| 2018-09-25 | Redmile Group, LLC | Director | Buy | 3,703,704.00 | 13.50 | 50,000,004.00 | 10,359,666.00 | https://www.sec.gov/Archives/edgar/data/1434316/000114420418051219/0001144204-18-051219-index.htm |
| 2020-01-08 | CINDY TAHL | General Counsel and Secretary | Buy | 25,000.00 | 105,218.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120003026/0001209191-20-003026-index.htm | ||
| 2020-10-01 | CINDY TAHL | General Counsel and Secretary | Sell | 6,260.00 | 41.09 | 257,234.04 | 106,501.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120053043/0001209191-20-053043-index.htm |
| 2020-11-05 | CINDY TAHL | General Counsel and Secretary | Buy | 9,282.00 | 2.73 | 25,339.86 | 108,800.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm |
| 2019-08-01 | Amir Nashat | Director | Sell | 29,782.00 | 22.53 | 670,970.59 | 1,099,772.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm |
| 2019-08-01 | Amir Nashat | Director | Sell | 299.00 | 22.53 | 6,736.32 | 11,034.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm |
| 2020-09-14 | Bahram Valamehr | Chief Development Officer | Sell | 600.00 | 34.65 | 20,791.98 | 111,611.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm |
| 2019-09-16 | Redmile Group, LLC | Director | Buy | 857,143.00 | 17.50 | 15,000,002.50 | 11,216,809.00 | https://www.sec.gov/Archives/edgar/data/1434316/000114420419044910/0001144204-19-044910-index.htm |
| 2020-09-14 | Bahram Valamehr | Chief Development Officer | Buy | 21,924.00 | 2.90 | 63,579.60 | 112,211.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm |
| 2020-10-01 | CINDY TAHL | General Counsel and Secretary | Sell | 21,757.00 | 40.26 | 875,902.01 | 112,761.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120053043/0001209191-20-053043-index.htm |
| 2019-07-31 | Amir Nashat | Director | Sell | 30,045.00 | 22.53 | 677,022.01 | 1,129,554.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm |
| 2019-07-31 | Amir Nashat | Director | Sell | 302.00 | 22.53 | 6,805.18 | 11,333.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm |
| 2019-02-25 | CINDY TAHL | General Counsel and Secretary | Buy | 25,000.00 | 2.90 | 72,500.00 | 115,418.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119014022/0001209191-19-014022-index.htm |
| 2019-03-01 | CINDY TAHL | General Counsel and Secretary | Buy | 25,000.00 | 2.90 | 72,500.00 | 115,418.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119016098/0001209191-19-016098-index.htm |
| 2019-07-30 | Amir Nashat | Director | Sell | 87,010.00 | 22.51 | 1,958,325.37 | 1,159,599.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm |
| 2019-07-30 | Amir Nashat | Director | Sell | 873.00 | 22.51 | 19,648.52 | 11,635.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm |
| 2020-09-14 | Daniel D Shoemaker | Chief Scientific Officer | Sell | 5,713.00 | 37.12 | 212,073.99 | 118,091.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120050681/0001209191-20-050681-index.htm |
| 2020-11-05 | CINDY TAHL | General Counsel and Secretary | Buy | 10,000.00 | 2.90 | 29,000.00 | 118,800.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm |
| 2019-10-15 | Daniel D Shoemaker | Chief Scientific Officer | Sell | 11,800.00 | 14.29 | 168,592.50 | 123,791.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119053272/0001209191-19-053272-index.htm |
| 2019-12-30 | Daniel D Shoemaker | Chief Scientific Officer | Sell | 100.00 | 20.34 | 2,034.00 | 123,791.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120000242/0001209191-20-000242-index.htm |
| 2020-09-14 | Daniel D Shoemaker | Chief Scientific Officer | Sell | 17,887.00 | 36.11 | 645,908.51 | 123,804.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120050681/0001209191-20-050681-index.htm |
| 2019-12-30 | Daniel D Shoemaker | Chief Scientific Officer | Sell | 24,900.00 | 19.49 | 485,393.13 | 123,891.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120000242/0001209191-20-000242-index.htm |
| 2019-07-29 | Amir Nashat | Director | Sell | 317.00 | 22.50 | 7,132.50 | 1,246,609.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm |
| 2019-07-26 | Amir Nashat | Director | Sell | 26,852.00 | 22.50 | 604,170.00 | 1,246,926.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm |
| 2019-07-29 | Amir Nashat | Director | Sell | 3.00 | 22.50 | 67.50 | 12,508.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm |
| 2019-07-26 | Amir Nashat | Director | Sell | 270.00 | 22.50 | 6,075.03 | 12,511.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm |
| 2020-06-11 | Redmile Group, LLC | Director | Buy | 1,412,928.00 | 28.31 | 39,999,991.68 | 12,629,737.00 | https://www.sec.gov/Archives/edgar/data/1434316/000110465920074301/0001104659-20-074301-index.htm |
| 2019-07-24 | Amir Nashat | Director | Sell | 19,168.00 | 22.51 | 431,389.26 | 1,273,778.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm |
| 2019-07-24 | Amir Nashat | Director | Sell | 192.00 | 22.51 | 4,321.09 | 12,781.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm |
| 2020-10-16 | CINDY TAHL | General Counsel and Secretary | Buy | 29,199.00 | 2.73 | 79,713.27 | 128,717.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120055368/0001209191-20-055368-index.htm |
| 2019-07-23 | Amir Nashat | Director | Sell | 59,854.00 | 22.51 | 1,347,014.27 | 1,292,946.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm |
| 2019-07-23 | Amir Nashat | Director | Sell | 601.00 | 22.51 | 13,525.51 | 12,973.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm |
| 2020-10-01 | CINDY TAHL | General Counsel and Secretary | Buy | 35,000.00 | 2.73 | 95,550.00 | 134,518.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120053043/0001209191-20-053043-index.htm |
| 2019-07-22 | Amir Nashat | Director | Sell | 46,992.00 | 22.52 | 1,058,457.21 | 1,352,800.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm |
| 2019-01-07 | Daniel D Shoemaker | Chief Scientific Officer | Buy | 45,000.00 | 135,591.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119003019/0001209191-19-003019-index.htm | ||
| 2019-03-28 | Daniel D Shoemaker | Chief Scientific Officer | Sell | 12,500.00 | 16.94 | 211,702.50 | 135,591.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119021717/0001209191-19-021717-index.htm |
| 2019-06-27 | Daniel D Shoemaker | Chief Scientific Officer | Sell | 12,500.00 | 20.21 | 252,610.00 | 135,591.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119039461/0001209191-19-039461-index.htm |
| 2019-07-22 | Amir Nashat | Director | Sell | 472.00 | 22.52 | 10,631.38 | 13,574.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm |
| 2019-07-19 | Amir Nashat | Director | Sell | 1,016.00 | 22.50 | 22,860.00 | 1,399,792.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm |
| 2019-07-18 | Amir Nashat | Director | Sell | 20,656.00 | 22.50 | 464,848.82 | 1,400,808.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm |
| 2019-07-19 | Amir Nashat | Director | Sell | 10.00 | 22.50 | 225.00 | 14,046.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm |
| 2019-07-18 | Amir Nashat | Director | Sell | 208.00 | 22.50 | 4,680.92 | 14,056.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm |
| 2020-09-14 | Daniel D Shoemaker | Chief Scientific Officer | Sell | 1,400.00 | 35.40 | 49,557.06 | 141,691.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120050681/0001209191-20-050681-index.htm |
| 2020-01-08 | Daniel D Shoemaker | Chief Scientific Officer | Sell | 5,700.00 | 20.70 | 117,986.01 | 143,091.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120003025/0001209191-20-003025-index.htm |
| 2019-01-30 | Amir Nashat | Director | Sell | 463.00 | 14.16 | 6,558.16 | 1,473,186.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002335/0000899243-19-002335-index.htm |
| 2019-01-30 | Amir Nashat | Director | Sell | 340.00 | 14.16 | 4,815.93 | 1,473,649.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002335/0000899243-19-002335-index.htm |
| 2019-01-30 | Amir Nashat | Director | Sell | 990.00 | 14.16 | 14,022.86 | 1,473,989.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002335/0000899243-19-002335-index.htm |
| 2019-01-30 | Amir Nashat | Director | Sell | 51,224.00 | 14.16 | 725,562.35 | 1,474,979.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002335/0000899243-19-002335-index.htm |
| 2019-03-28 | Daniel D Shoemaker | Chief Scientific Officer | Buy | 12,500.00 | 2.90 | 36,250.00 | 148,091.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119021717/0001209191-19-021717-index.htm |
| 2019-06-27 | Daniel D Shoemaker | Chief Scientific Officer | Buy | 12,500.00 | 2.90 | 36,250.00 | 148,091.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119039461/0001209191-19-039461-index.htm |
| 2019-12-30 | Daniel D Shoemaker | Chief Scientific Officer | Buy | 25,000.00 | 2.90 | 72,500.00 | 148,791.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120000242/0001209191-20-000242-index.htm |
| 2020-01-08 | Daniel D Shoemaker | Chief Scientific Officer | Buy | 25,000.00 | 148,791.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120003025/0001209191-20-003025-index.htm | ||
| 2020-11-04 | CINDY TAHL | General Counsel and Secretary | Buy | 51,519.00 | 2.73 | 140,646.87 | 151,037.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm |
| 2019-01-29 | Amir Nashat | Director | Sell | 941.00 | 14.16 | 13,326.44 | 1,526,203.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002256/0000899243-19-002256-index.htm |
| 2019-01-29 | Amir Nashat | Director | Sell | 644.00 | 14.16 | 9,120.33 | 1,527,144.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002256/0000899243-19-002256-index.htm |
| 2019-01-29 | Amir Nashat | Director | Sell | 1,834.00 | 14.16 | 25,973.29 | 1,527,788.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002256/0000899243-19-002256-index.htm |
| 2019-01-29 | Amir Nashat | Director | Sell | 94,081.00 | 14.16 | 1,332,375.12 | 1,529,622.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002256/0000899243-19-002256-index.htm |
| 2019-01-28 | Amir Nashat | Director | Sell | 675.00 | 13.78 | 9,303.12 | 1,623,703.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002196/0000899243-19-002196-index.htm |
| 2019-01-28 | Amir Nashat | Director | Sell | 463.00 | 13.78 | 6,381.25 | 1,624,378.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002196/0000899243-19-002196-index.htm |
| 2019-01-28 | Amir Nashat | Director | Sell | 1,316.00 | 13.78 | 18,137.64 | 1,624,841.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002196/0000899243-19-002196-index.htm |
| 2019-01-28 | Amir Nashat | Director | Sell | 67,546.00 | 13.78 | 930,945.99 | 1,626,157.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002196/0000899243-19-002196-index.htm |
| 2019-01-25 | Amir Nashat | Director | Sell | 868.00 | 14.14 | 12,275.00 | 1,693,703.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002114/0000899243-19-002114-index.htm |
| 2019-01-25 | Amir Nashat | Director | Sell | 595.00 | 14.14 | 8,414.31 | 1,694,571.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002114/0000899243-19-002114-index.htm |
| 2019-01-25 | Amir Nashat | Director | Sell | 1,693.00 | 14.14 | 23,941.90 | 1,695,166.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002114/0000899243-19-002114-index.htm |
| 2019-01-25 | Amir Nashat | Director | Sell | 86,844.00 | 14.14 | 1,228,121.79 | 1,696,859.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319002114/0000899243-19-002114-index.htm |
| 2019-01-18 | Amir Nashat | Director | Sell | 381.00 | 16.28 | 6,203.06 | 1,783,703.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319001724/0000899243-19-001724-index.htm |
| 2019-01-18 | Amir Nashat | Director | Sell | 261.00 | 16.28 | 4,249.34 | 1,784,084.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319001724/0000899243-19-001724-index.htm |
| 2019-01-18 | Amir Nashat | Director | Sell | 743.00 | 16.28 | 12,097.01 | 1,784,345.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319001724/0000899243-19-001724-index.htm |
| 2019-01-18 | Amir Nashat | Director | Sell | 38,098.00 | 16.28 | 620,284.97 | 1,785,088.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319001724/0000899243-19-001724-index.htm |
| 2018-12-20 | Amir Nashat | Director | Sell | 323.00 | 12.25 | 3,957.75 | 1,823,186.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031703/0000899243-18-031703-index.htm |
| 2018-12-20 | Amir Nashat | Director | Sell | 221.00 | 12.25 | 2,707.94 | 1,823,509.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031703/0000899243-18-031703-index.htm |
| 2018-12-20 | Amir Nashat | Director | Sell | 630.00 | 12.25 | 7,719.45 | 1,823,730.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031703/0000899243-18-031703-index.htm |
| 2018-12-20 | Amir Nashat | Director | Sell | 32,300.00 | 12.25 | 395,775.13 | 1,824,360.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031703/0000899243-18-031703-index.htm |
| 2018-12-19 | Amir Nashat | Director | Sell | 240.00 | 13.96 | 3,351.10 | 1,856,660.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm |
| 2018-12-19 | Amir Nashat | Director | Sell | 640.00 | 13.19 | 8,444.54 | 1,856,900.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm |
| 2018-12-19 | Amir Nashat | Director | Sell | 180.00 | 13.96 | 2,513.30 | 1,857,540.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm |
| 2018-12-19 | Amir Nashat | Director | Sell | 423.00 | 13.17 | 5,569.39 | 1,857,720.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm |
| 2018-12-19 | Amir Nashat | Director | Sell | 454.00 | 13.96 | 6,337.43 | 1,858,143.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm |
| 2018-12-19 | Amir Nashat | Director | Sell | 1,261.00 | 13.20 | 16,650.62 | 1,858,597.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm |
| 2018-12-19 | Amir Nashat | Director | Sell | 23,023.00 | 13.96 | 321,364.24 | 1,859,858.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm |
| 2018-12-19 | Amir Nashat | Director | Sell | 64,989.00 | 13.21 | 858,361.71 | 1,882,881.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031588/0000899243-18-031588-index.htm |
| 2018-12-13 | Amir Nashat | Director | Sell | 172.00 | 16.67 | 2,867.60 | 1,947,870.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031217/0000899243-18-031217-index.htm |
| 2018-12-13 | Amir Nashat | Director | Sell | 118.00 | 16.67 | 1,967.31 | 1,948,042.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031217/0000899243-18-031217-index.htm |
| 2018-12-13 | Amir Nashat | Director | Sell | 334.00 | 16.67 | 5,568.48 | 1,948,160.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031217/0000899243-18-031217-index.htm |
| 2018-12-13 | Amir Nashat | Director | Sell | 17,164.00 | 16.67 | 286,159.92 | 1,948,494.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031217/0000899243-18-031217-index.htm |
| 2018-12-12 | Amir Nashat | Director | Sell | 4,101.00 | 16.78 | 68,826.26 | 1,965,658.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031090/0000899243-18-031090-index.htm |
| 2018-12-12 | Amir Nashat | Director | Sell | 2,809.00 | 16.78 | 47,142.89 | 1,969,759.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031090/0000899243-18-031090-index.htm |
| 2018-12-12 | Amir Nashat | Director | Sell | 7,993.00 | 16.78 | 134,144.92 | 1,972,568.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031090/0000899243-18-031090-index.htm |
| 2018-12-12 | Amir Nashat | Director | Sell | 410,097.00 | 16.78 | 6,882,575.93 | 1,980,561.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318031090/0000899243-18-031090-index.htm |
| 2019-08-01 | Amir Nashat | Director | Sell | 581.00 | 22.53 | 13,089.58 | 21,438.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm |
| 2019-07-31 | Amir Nashat | Director | Sell | 586.00 | 22.53 | 13,204.63 | 22,019.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm |
| 2019-07-30 | Amir Nashat | Director | Sell | 1,696.00 | 22.51 | 38,171.70 | 22,605.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm |
| 2018-12-11 | Amir Nashat | Director | Sell | 796.00 | 16.71 | 13,302.51 | 2,390,658.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318030904/0000899243-18-030904-index.htm |
| 2018-12-11 | Amir Nashat | Director | Sell | 546.00 | 16.71 | 9,124.59 | 2,391,454.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318030904/0000899243-18-030904-index.htm |
| 2018-12-11 | Amir Nashat | Director | Sell | 1,552.00 | 16.71 | 25,936.56 | 2,392,000.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318030904/0000899243-18-030904-index.htm |
| 2018-12-11 | Amir Nashat | Director | Sell | 79,634.00 | 16.71 | 1,330,819.52 | 2,393,552.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924318030904/0000899243-18-030904-index.htm |
| 2019-07-29 | Amir Nashat | Director | Sell | 6.00 | 22.50 | 135.00 | 24,301.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm |
| 2019-07-26 | Amir Nashat | Director | Sell | 523.00 | 22.50 | 11,767.50 | 24,307.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm |
| 2019-07-24 | Amir Nashat | Director | Sell | 374.00 | 22.51 | 8,417.13 | 24,830.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm |
| 2019-07-23 | Amir Nashat | Director | Sell | 1,167.00 | 22.51 | 26,263.34 | 25,204.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm |
| 2019-07-22 | Amir Nashat | Director | Sell | 917.00 | 22.52 | 20,654.69 | 26,371.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm |
| 2019-07-19 | Amir Nashat | Director | Sell | 20.00 | 22.50 | 450.00 | 27,288.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm |
| 2019-07-18 | Amir Nashat | Director | Sell | 403.00 | 22.50 | 9,069.19 | 27,308.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm |
| 2020-03-30 | WILLIAM H RASTETTER | Director | Buy | 28,461.00 | 1.37 | 38,991.57 | 28,461.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120021788/0001209191-20-021788-index.htm |
| 2019-10-15 | J Scott Wolchko | President and CEO | Sell | 21,017.00 | 14.44 | 303,458.16 | 353,969.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119053280/0001209191-19-053280-index.htm |
| 2019-12-19 | J Scott Wolchko | President and CEO | Sell | 25,000.00 | 20.08 | 501,897.50 | 353,969.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119061760/0001209191-19-061760-index.htm |
| 2019-12-20 | J Scott Wolchko | President and CEO | Sell | 25,000.00 | 20.17 | 504,157.50 | 353,969.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119061760/0001209191-19-061760-index.htm |
| 2019-01-07 | J Scott Wolchko | President and CEO | Buy | 250,000.00 | 374,881.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119003023/0001209191-19-003023-index.htm | ||
| 2019-03-21 | J Scott Wolchko | President and CEO | Sell | 20,000.00 | 17.61 | 352,160.00 | 374,881.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119020986/0001209191-19-020986-index.htm |
| 2019-04-17 | J Scott Wolchko | President and CEO | Sell | 1,092.00 | 16.11 | 17,587.97 | 374,881.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm |
| 2019-04-17 | J Scott Wolchko | President and CEO | Sell | 7,449.00 | 16.18 | 120,544.19 | 374,881.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm |
| 2019-04-18 | J Scott Wolchko | President and CEO | Sell | 6,843.00 | 16.01 | 109,583.80 | 374,881.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm |
| 2019-04-18 | J Scott Wolchko | President and CEO | Sell | 4,616.00 | 16.02 | 73,925.24 | 374,881.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm |
| 2019-05-16 | J Scott Wolchko | President and CEO | Sell | 12,037.00 | 19.54 | 235,253.54 | 374,881.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319014037/0000899243-19-014037-index.htm |
| 2019-04-17 | J Scott Wolchko | President and CEO | Buy | 1,092.00 | 1.63 | 1,779.96 | 375,973.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm |
| 2019-12-19 | J Scott Wolchko | President and CEO | Buy | 25,000.00 | 2.70 | 67,500.00 | 378,969.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119061760/0001209191-19-061760-index.htm |
| 2019-12-20 | J Scott Wolchko | President and CEO | Buy | 25,000.00 | 2.70 | 67,500.00 | 378,969.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119061760/0001209191-19-061760-index.htm |
| 2019-04-18 | J Scott Wolchko | President and CEO | Buy | 4,616.00 | 1.63 | 7,524.08 | 379,497.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm |
| 2019-04-18 | J Scott Wolchko | President and CEO | Buy | 6,843.00 | 1.63 | 11,154.09 | 381,724.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm |
| 2019-04-17 | J Scott Wolchko | President and CEO | Buy | 7,449.00 | 1.63 | 12,141.87 | 382,330.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119025373/0001209191-19-025373-index.htm |
| 2019-05-16 | J Scott Wolchko | President and CEO | Sell | 2,298.00 | 18.46 | 42,430.27 | 386,918.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319014037/0000899243-19-014037-index.htm |
| 2019-05-16 | J Scott Wolchko | President and CEO | Buy | 14,335.00 | 1.63 | 23,366.05 | 389,216.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319014037/0000899243-19-014037-index.htm |
| 2019-03-21 | J Scott Wolchko | President and CEO | Buy | 20,000.00 | 1.63 | 32,600.00 | 394,881.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119020986/0001209191-19-020986-index.htm |
| 2020-08-17 | Edward J III Dulac | Chief Financial Officer | Buy | 40,000.00 | 40,000.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120047483/0001209191-20-047483-index.htm | ||
| 2020-01-08 | J Scott Wolchko | President and CEO | Buy | 66,000.00 | 419,969.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120003031/0001209191-20-003031-index.htm | ||
| 2020-01-30 | J Scott Wolchko | President and CEO | Sell | 25,000.00 | 25.45 | 636,302.50 | 419,969.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120005968/0001209191-20-005968-index.htm |
| 2020-01-30 | J Scott Wolchko | President and CEO | Buy | 25,000.00 | 2.70 | 67,500.00 | 444,969.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120005968/0001209191-20-005968-index.htm |
| 2019-01-07 | CINDY TAHL | General Counsel and Secretary | Sell | 25,000.00 | 16.00 | 400,000.00 | 45,418.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm |
| 2019-01-07 | CINDY TAHL | General Counsel and Secretary | Buy | 2,008.00 | 1.37 | 2,750.96 | 47,426.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm |
| 2019-01-07 | CINDY TAHL | General Counsel and Secretary | Buy | 2,080.00 | 1.69 | 3,515.20 | 49,506.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm |
| 2019-01-07 | CINDY TAHL | General Counsel and Secretary | Buy | 8,461.00 | 1.69 | 14,299.09 | 57,967.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm |
| 2019-10-15 | Bahram Valamehr | Chief Development Officer | Sell | 6,200.00 | 14.18 | 87,890.58 | 66,758.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119053277/0001209191-19-053277-index.htm |
| 2019-01-07 | CINDY TAHL | General Counsel and Secretary | Buy | 12,451.00 | 2.90 | 36,107.90 | 70,418.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm |
| 2019-01-07 | Bahram Valamehr | Chief Development Officer | Buy | 45,000.00 | 72,958.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119003022/0001209191-19-003022-index.htm | ||
| 2019-08-01 | Amir Nashat | Director | Sell | 204.00 | 22.53 | 4,596.00 | 7,539.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm |
| 2019-07-31 | Amir Nashat | Director | Sell | 206.00 | 22.53 | 4,641.98 | 7,743.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020915/0000899243-19-020915-index.htm |
| 2019-07-30 | Amir Nashat | Director | Sell | 596.00 | 22.51 | 13,414.11 | 7,949.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm |
| 2019-10-15 | CINDY TAHL | General Counsel and Secretary | Sell | 10,200.00 | 14.24 | 145,291.86 | 80,218.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119053275/0001209191-19-053275-index.htm |
| 2019-07-29 | Amir Nashat | Director | Sell | 3.00 | 22.50 | 67.50 | 8,545.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm |
| 2019-07-26 | Amir Nashat | Director | Sell | 184.00 | 22.50 | 4,140.00 | 8,548.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020605/0000899243-19-020605-index.htm |
| 2020-01-08 | Bahram Valamehr | Chief Development Officer | Sell | 5,700.00 | 20.69 | 117,947.25 | 86,058.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120003027/0001209191-20-003027-index.htm |
| 2020-02-03 | Bahram Valamehr | Chief Development Officer | Buy | 1,153.00 | 1.69 | 1,948.57 | 87,211.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120006263/0001209191-20-006263-index.htm |
| 2020-09-14 | Bahram Valamehr | Chief Development Officer | Sell | 600.00 | 37.49 | 22,494.00 | 87,211.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm |
| 2019-07-24 | Amir Nashat | Director | Sell | 132.00 | 22.51 | 2,970.77 | 8,732.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm |
| 2020-09-14 | Bahram Valamehr | Chief Development Officer | Sell | 7,016.00 | 36.93 | 259,084.74 | 87,811.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm |
| 2019-07-23 | Amir Nashat | Director | Sell | 411.00 | 22.51 | 9,249.60 | 8,864.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020426/0000899243-19-020426-index.htm |
| 2020-09-14 | Bahram Valamehr | Chief Development Officer | Buy | 3,076.00 | 1.69 | 5,198.44 | 90,287.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm |
| 2019-01-07 | CINDY TAHL | General Counsel and Secretary | Buy | 45,000.00 | 90,418.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119003020/0001209191-19-003020-index.htm | ||
| 2019-02-25 | CINDY TAHL | General Counsel and Secretary | Sell | 25,000.00 | 16.07 | 401,820.00 | 90,418.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119014022/0001209191-19-014022-index.htm |
| 2019-03-01 | CINDY TAHL | General Counsel and Secretary | Sell | 25,000.00 | 16.15 | 403,697.50 | 90,418.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919119016098/0001209191-19-016098-index.htm |
| 2020-01-08 | Bahram Valamehr | Chief Development Officer | Buy | 25,000.00 | 91,758.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120003027/0001209191-20-003027-index.htm | ||
| 2019-07-22 | Amir Nashat | Director | Sell | 323.00 | 22.52 | 7,275.35 | 9,275.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm |
| 2020-09-14 | Bahram Valamehr | Chief Development Officer | Sell | 16,784.00 | 36.03 | 604,653.67 | 94,827.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120050683/0001209191-20-050683-index.htm |
| 2019-07-19 | Amir Nashat | Director | Sell | 7.00 | 22.50 | 157.50 | 9,598.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm |
| 2019-07-18 | Amir Nashat | Director | Sell | 142.00 | 22.50 | 3,195.61 | 9,605.00 | https://www.sec.gov/Archives/edgar/data/1434316/000089924319020033/0000899243-19-020033-index.htm |
| 2020-01-08 | CINDY TAHL | General Counsel and Secretary | Sell | 5,700.00 | 20.72 | 118,085.19 | 99,518.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120003026/0001209191-20-003026-index.htm |
| 2020-10-01 | CINDY TAHL | General Counsel and Secretary | Sell | 6,983.00 | 41.95 | 292,929.17 | 99,518.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120053043/0001209191-20-053043-index.htm |
| 2020-10-16 | CINDY TAHL | General Counsel and Secretary | Sell | 29,199.00 | 50.25 | 1,467,211.79 | 99,518.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120055368/0001209191-20-055368-index.htm |
| 2020-11-04 | CINDY TAHL | General Counsel and Secretary | Sell | 51,519.00 | 50.41 | 2,597,139.76 | 99,518.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm |
| 2020-11-05 | CINDY TAHL | General Counsel and Secretary | Sell | 2,600.00 | 51.15 | 132,998.58 | 99,518.00 | https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/0001209191-20-057265-index.htm |